Browse articles from EyeWorld.org related to MIGS. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Study: protein patterns in tears predict postop pain ➤ Tentative approval for generic glaucoma drug ➤ Nanodrug recovers optic nerve in glaucoma animal model ➤ Acquisition news ➤ ASCRS news and events
Recent changes to training have seen the addition of a requirement for trainees to perform five MIGS procedures as the primary surgeon. Requirements for tube shunts and trabeculectomy remain in place, but those in training can be the surgeon or assistant on five procedures. Several surgeons weighed in on these changes.
➤ Allogenic cell therapy receives FDA designations ➤ Robot delivers new treatment for wet AMD ➤ Health-related quality of life measure proposed for MIGS ➤ Company meets with FDA for pediatric myopia drug candidate ➤ ASCRS news and events
A 2024 ASCRS Annual Meeting symposium featured quick-hit tips from glaucoma specialists. Panelists were asked to share a 1-minute pearl in a variety of categories and included Sarah Van Tassel, MD, Kuldev Singh, MD, MPH, Douglas Rhee, MD, Lorraine Provencher, MD, and Christopher Teng, MD, MBA.
➤ Topline results for investigational diabetic retinopathy therapy ➤ Dosing complete in second cohort for Phase 1/2 trial for geographic atrophy therapy ➤ Large data modules launched for dry eye disease and thyroid eye disease ➤ Study: Real-world outcomes of MIGS combined with cataract surgery vs. cataract surgery alone ➤ ASCRS news and events
Glaucoma surgeons recently faced a potentially disastrous reimbursement situation when five Medicare Administrative Contractors proposed and finalized limiting coverage of several MIGS procedures. Because of extensive advocacy efforts, it was announced that there would be no change in the coverage at this time.
➤ ASCRS advocacy helps protect MIGS coverage ➤ FDA approves generic loteprednol etabonate ophthalmic suspension ➤ Orphan Drug Designation granted for corneal endothelial cell substitute ➤ Positive results in Phase 2 clinical trial for contact lens discomfort ➤ First patient visits ➤ Acquisition news ➤ Complimentary access to video journal ➤ ASCRS news and events
➤ Study: large-scale MIGS study ➤ Partnership to advance early disease detection ➤ License agreement to move forward option for cataract surgery sedation ➤ Name change news ➤ ASCRS news and events
Two experts, including Glaucoma Editor Manjool Shah, MD, spoke about the complications during and after MIGS procedures that the surgeon needs to be prepared to identify and address.
This article recaps the 2023 Richard L. Lindstrom, MD, Lecture, titled “Glaucoma Surgery: Taking it to the Next Level,” given by Marlene Moster, MD, as well as the other presentations in the session, given by Cathleen McCabe, MD, Francis Mah, MD, and Daniel Chang, MD.